CD30在癌症诊断和治疗中的多用途作用

相关实验视频

Updated: Jul 23, 2025

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Adrian Vasile Dumitru^1,2, Dana Antonia Țăpoi^1,2, Georgian Halcu^1,3

¹Department of Pathology, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

|July 14, 2023

概括

CD30 (瘤坏死因子受体超级家族成员8) 是诊断淋巴瘤和其他癌症的关键瘤标志物. 向CD30为这些疾病和潜在的自身免疫性疾病提供了一个有前途的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
细胞生物学细胞生物学

背景情况:

CD30,也称为TNFRSF8,是一种高度糖化蛋白质受体.
它作为一种在特定的免疫和癌细胞上发现的瘤标志物起作用.
CD30表达对于诊断各种恶性瘤至关重要.

研究的目的:

审查CD30.0的多方面的作用.
突出其在疾病诊断和治疗向方面的意义.
探索其在治疗淋巴瘤和自身免疫性疾病方面的潜力.

主要方法:

对CD30的生物功能进行文献综述.
分析CD30在特定癌症诊断中的作用.
检查CD30向疗法和正在进行的研究.

主要成果:

CD30在霍奇金淋巴瘤,胚胎癌,ALCL和CTCL细胞上表达.
它作为这些条件的关键诊断标记.
向CD30表明了对CD30阳性淋巴瘤的治疗潜力.

结论:

CD30是一种重要的瘤标志物,具有诊断和治疗意义.
针对CD30的疗法对淋巴瘤有效,并可能有利于自身免疫性疾病.
进一步的研究支持CD30作为细胞静止治疗的目标.

关键词:

CD3030 是一个CD3030 是一个CD30.霍奇金淋巴瘤是一种霍奇金淋巴瘤.形性大细胞淋巴瘤癌症治疗治疗治疗癌症胚胎癌细胞瘤是什么瘤标志物是一种瘤标志物.

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Murine Model of CD40-activation of B cells

Murine Model of CD40-activation of B cells

Published on: March 5, 2010

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...